Onion and garlic intake and the odds of benign prostatic hyperplasia

被引:19
|
作者
Galeone, Carlotta
Pelucchi, Claudio
Talamini, Renato
Negri, Eva
Dal Maso, Luigino
Montella, Maurizio
Ramazzotti, Valerio
Franceschi, Silvia
La Vecchia, Carlo
机构
[1] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
[2] Univ Milan, Ist Stat Med & Biometria Giulio A Maccacaro, Milan, Italy
[3] Ctr Riferimento Oncol, Unita Epidemiol & Biostat, I-33081 Aviano, PN, Italy
[4] Ist Tumori Fdn Pascale, Serv Epidemiol, Naples, FL USA
[5] Ist Nazl Tumori, Serv Integrato Epidemiol & Sist Informat, Rome, Italy
[6] Int Agcy Res Canc, F-69372 Lyon, France
关键词
D O I
10.1016/j.urology.2007.06.1099
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBIECTIVE To analyze the relationship between onion and garlic intake and benign prostatic hyperplasia (BPH), using data from a multicenter case-control Study conducted in Italy. METHODS A multicenter case-control study of 1369 patients with BPH and 1451 controls, admitted to the same hospitals for a wide spectrum of acute, non-neoplastic conditions, was conducted in Italy between 1991 and 2002. Information was collected by trained interviewers using a validated and reproducible food frequency questionnaire. Multivariate odds ratios (ORs) and 95% confidence intervals (CIs) were obtained after allowance for recognized confounding factors and energy intake. RESULTS Compared with nonusers, the multivariate ORs for the highest category of onion and garlic intake were 0.41 (95% CI 0.24 to 0.72) and 0.72 (95% CI 0.57 to 0.91), respectively. The combined OR for frequent users versus nonusers of both onion and garlic was 0.65 (95% CI 0.49 to 0.86). The inverse relationships were consistent across age strata. CONCLUSIONS This uniquely large data set from European populations showed an inverse association between allium vegetable consumption and BPH.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 50 条
  • [41] Benign prostatic hyperplasia
    Doherty, AP
    HOSPITAL MEDICINE, 2003, 64 (02): : 114 - 114
  • [42] Prostatic stents for benign prostatic hyperplasia
    Klein, LT
    Kaplan, SA
    JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS, 1997, 7 (01) : 101 - 114
  • [43] PHARMACOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA
    NARAYAN, P
    INDUDHARA, R
    WESTERN JOURNAL OF MEDICINE, 1994, 161 (05): : 495 - 506
  • [44] EPIDEMIOLOGY OF BENIGN PROSTATIC HYPERPLASIA
    OLEARY, MP
    BRITISH JOURNAL OF UROLOGY, 1995, 76 : 1 - 3
  • [45] MASSIVE BENIGN PROSTATIC HYPERPLASIA
    TOLLEY, DA
    ENGLISH, PJ
    GRIGOR, KM
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1987, 80 (12) : 777 - 778
  • [46] OBESITY AND BENIGN PROSTATIC HYPERPLASIA
    GIOVANNUCCI, E
    RIMM, EB
    CHUTE, CG
    KAWACHI, I
    COLDITZ, GA
    STAMPFER, MJ
    WILLETT, WC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (11) : 989 - 1002
  • [47] ETIOLOGY OF BENIGN PROSTATIC HYPERPLASIA
    ISAACS, JT
    EUROPEAN UROLOGY, 1993, 25 : 6 - 9
  • [48] Finasteride for benign prostatic hyperplasia
    Tacklind, J.
    Fink, H. A.
    MacDonald, R.
    Rutks, I
    Wilt, T. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (10):
  • [49] Exophytic Benign Prostatic Hyperplasia
    Blaschko, Sarah D.
    Eisenberg, Michael L.
    UROLOGY, 2011, 78 (02) : 322 - 322
  • [50] Pathology of benign prostatic hyperplasia
    C G Roehrborn
    International Journal of Impotence Research, 2008, 20 : S11 - S18